Dietary diacylglycerol induces the regression of atherosclerosis in rabbits.
Recent studies of the relation between serum triacylglycerol concentration and the risk for coronary artery disease suggest that inefficient clearance of postprandial triacylglycerols promotes atherogenesis. We recently demonstrated that dietary diacylglycerol (DAG), rich in the 1,3-species, suppresses the postprandial increase in serum triacylglycerol levels compared with dietary triacylglycerol (TAG). Here, we investigated the effects of dietary DAG on atherosclerosis in rabbits with cholesterol-induced atherosclerosis. New Zealand White rabbits (n = 20) were fed a diet containing 3% lard and 1.3% cholesterol for 50 d to induce atherosclerotic lesions. Thereafter, the rabbits were assigned to 2 groups and fed 90 g/d nonpurified diet and orally administered 5 g DAG or TAG for an additional 34 d. Reference rabbits (n = 5) were fed only the nonpurified diet throughout the 84-d study. The area of atherosclerotic lesions and aortic lipid concentrations were significantly lower in DAG-fed rabbits compared with TAG-fed rabbits. The VLDL receptor and macrophage antigen-1 mRNA expression levels were significantly lower in DAG-fed rabbits than in TAG-fed rabbits. In the liver of DAG-fed rabbits, the triacylglycerol concentration was lower and the carnitine palmitoyltransferase activity higher than in TAG-fed rabbits. Stimulation of hepatic lipid catabolism might be related to the reduced lipid accumulation in the liver and aorta by reducing the release of triacylglycerol into the circulation. Thus, long-term consumption of DAG, which reduces postprandial lipemia, might be useful for the regression of atherosclerosis by stimulating hepatic lipid catabolism and thereby modulating monocyte/macrophage migration and aortic lipid accumulation.
Ota
Noriyasu
N
Biological Science Laboratories, Kao Corporation, Tochigi 321-3497, Japan. ota.noriyasu@kao.co.jp
Soga
Satoko
S
Hase
Tadashi
T
Tokimitsu
Ichiro
I
Murase
Takatoshi
T
D000818:Animals; D001011:Aorta / Q000473:pathology; D050197:Atherosclerosis / Q000178:diet therapy* / Q000378:metabolism / Q000473:pathology*; D002334:Carnitine O-Palmitoyltransferase / Q000378:metabolism; D004032:Diet; D004075:Diglycerides / Q000008:administration & dosage*; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D008099:Liver / Q000201:enzymology / Q000378:metabolism; D008297:Male; D012333:RNA, Messenger / Q000378:metabolism; D011817:Rabbits; D014280:Triglycerides / Q000008:administration & dosage / Q000378:metabolism
D004075:Diglycerides; D008055:Lipids; D012333:RNA, Messenger; D014280:Triglycerides; D002334:Carnitine O-Palmitoyltransferase